Release Date: 28/07/14 12:08 Summary: Quarterly Report June 2014 Price Sensitive: Yes Download Document 4.03MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%